[1] Lalioti V, Sandoval I, Cassio D, et al. Molecular pathology of Wilson's disease: a brief. J Hepatol, 2010, 53(6): 1151-1153. [2] 中华医学会肝病学分会遗传代谢性肝病协作组. 肝豆状核变性诊疗指南(2022年版). 中华肝脏病杂志, 2022, 30(1): 9-20. [3] 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗指南(2022 年版). 中华肝脏病杂志, 2022, 30(4): 367-388. [4] Llovet JM, Brú C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis, 1999, 19(3):329-338. [5] Sandahl TD, Laursen TL, Munk DE, et al. The prevalence of wilson's disease: an update. Hepatology, 2020, 71(2):722-732. [6] Nagral A, Sarma MS, Matthai J et al. Wilson's disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India. J Clin Exp Hepatol, 2019, 9(1): 74-98. [7] Gerosa C, Fanni D, Congiu T, et al. Liver pathology in Wilson's disease: from copper overload to cirrhosis. J Inorg Biochem, 2019 Apr;193:106-111. [8] Litwin T, Gromadzka G, Członkowska A. Gender differences in Wilson's disease. J Neurol Sci, 2012, 312(1-2):31-35. [9] van Meer S, de Man RA, van den Berg AP, et al. No increased risk of hepatocellular carcinoma in cirrhosis due to Wilson disease during long-term follow-up. J Gastroenterology Hepatol. 2015, 30(3): 535-539. [10] Pfeiffenberger J, Mogler C, Gotthardt DN, et al. Hepatobiliary malignancies in Wilson disease. Liver Int, 2015, 35(5):1615-1622. [11] Wilkinson ML, Portmann B, Williams R. Wilson's disease and hepatocellular carcinoma: possible protective role of copper. Gut, 1983, 24(8): 767-771. [12] Kato J, Kobune M, Kohgo Y, et al. Hepatic iron deprivation prevents spontaneous development of fulminant hepatitis and liver cancer in Long-Evans Cinnamon rats. J Clin Invest, 1996, 98(4): 923-929. [13] Medici V, Di Leo V, Lambogila F, et al. Effect of penicillamine and zinc on iron metabolism in Wilson's disease. Scand J Gastroenterol, 2007, 42(12): 1495-1500. [14] European Association for Study of Liver. EASL Clinical Practice Guidelines: Wilson's disease. J Hepatol, 2012, 56(3):671-85. [15] Sheline CT. Thiamine supplementation attenuated hepatocellular carcinoma in the Atp7b mouse model of Wilson's disease. Anticancer Res. 2011, 31(10): 3395-3399. [16] Thattil R, Dufour JF. Hepatocellular carcinoma in a non-cirrhotic patient with Wilson's disease. World J Hepatol. 2013, 19(13): 2110-2113. [17] Gui CH, Baey S, D'cruz RT, et al. Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma-a meta-analysis. Eur J Surg Oncol, 2020, 46(5):763-771. [18] Arnon R, Annunziato R, Schilsky M. Liver transplantation for children with Wilson disease: comparison of outcomes between children and adults. Clin Transplant, 2011, 25(1): E52-60. |